Smartzyme Biopharma

SmartZyme is a life science company using PROVOLUTION™, a proprietary technological platform for protein design and engineering, in accordance with industry required specifications. The company was founded in November 2013 by Shilo Ben Zeev (CEO) and David Baram, Ph.D.(CTO). The company aims to efficiently design and create proteins and potent enzymes with the specific characteristics required for optimal performance. Its products will be used to revolutionize industries by addressing unmet needs of various industrial fields. The company’s PROVOLUTION™ technology combines some of the most advanced scientific tools for protein engineering, computational biology and electrochemistry. These tools enable the development of improved, or “superior”, proteins and enzymes for wide ranging applications. The Company is currently focusing on the Diabetes market where it intends to launch its first two products: a pre-designed enzyme with superior characteristics for improved bio-electrochemical glucose catalysis, to be used on glucose test strips for the Self Monitoring Blood Glucose (SMBG) market. Strip manufacturers incorporating this superior enzyme in their products will be able to offer results which are far more accurate than current standard strips and ensure that their strips meet the rigid ISO 15197:2013 requirements. The company’s second product, the Go Patch Go™, personalized patient care system (PCS), an on-demand blood glucose measurement system in which measurement accuracy, enzyme stability and product shelf life are significantly enhanced due to the use of SmartZyme’s protein engineering technology. This product will offer diabetic patients a solution to current blood glucose monitoring systems which lack the optimal accuracy and stability required for effective treatment for diabetes. SmartZyme’s R&D efforts are supported by a scientific advisory board of leaders in the fields of protein engineering, structural biology and electrochemistry.